An investigation of the molecular mechanisms contributing to high-level erythromycin resistance in Campylobacter

International Journal of Antimicrobial Agents

Volumn 27, Issue 1, 2006, Pages 40-45

  Corcoran, Deborah ^a,b   Quinn, Teresa ^a   Cotter, Leslie ^b   Fanning, Séamus ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b Munster Technological University   (Ireland)

Author keywords

Campylobacter; Efflux; Erythromycin; Ribosomal proteins

Indexed keywords

AMIDE; ERYTHROMYCIN; LEVO PHENYLALANINE LEVO ARGININE BETA NAPHTHYLAMIDE; RIBOSOME RNA; RNA 23S; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; BACTERIUM ISOLATE; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; DRUG SENSITIVITY; GENE DELETION; GENE INSERTION; GENE MUTATION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR MECHANICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RIBOSOME SUBUNIT;

AMINO ACID SEQUENCE; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; RIBOSOMAL PROTEINS; RNA, RIBOSOMAL, 23S;

EID: 29944443936     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2005.08.019     Document Type: Article

References (28)

1. F.M. Aarestrup, and J. Engberg Antimicrobial resistance of thermophilic Campylobacter Vet Res 32 2001 311 321
2. B.M. Allos Campylobacter jejuni infections: update on emerging issues and trends Clin Infect Dis 32 2001 1201 1206
3. J. Engberg, F.M. Aarestrup, D.E. Taylor, P. Gerner-Smidt, and I. Nachamkin Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates Emerg Infect Dis 7 2001 24 34
4. B. Lucey, B. Cryan, F. O'Halloran, P.G. Wall, T. Buckely, and S. Fanning Trends in antimicrobial susceptibility among isolates of Campylobacter species in Ireland and the emergence of resistance to ciprofloxacin Vet Rec 151 2002 317 320
5. J. Engberg, J. Neimann, E.M. Nielsen, F.M. Aerestrup, and V. Fussing Quinolone-resistant Campylobacter infections: risk factors and clinical consequences Emerg Infect Dis 10 2004 1056 1063
6. K. Pedersen, and A. Wedderkopp Resistance to quinolones in Campylobacter jejuni and Campylobacter coli from Danish broilers at farm level J Appl Microbiol 94 2003 111 119
7. K. Ishihara, T. Kira, and K. Ogikubo Antimicrobial susceptibilities of Campylobacter isolated from food-producing animals on farms (1999-2001) results from the Japanese Veterinary Antimicrobial Resistance Monitoring Program Int J Antimicrob Agents 24 2004 261 267
8. Y. Saenz, M. Zarazaga, M. Lantero, M.J. Gastanares, F. Baquero, and C. Torres Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998 Antimicrob Agents Chemother 44 2000 267 271
9. B. Weisblum Erythromycin resistance by ribosome modification Antimicrob Agents Chemother 39 1995 577 585
10. S. Vacher, A. Menard, E. Bernard, A. Santos, and F. Megraud Detection of mutations associated with macrolide resistance in thermophilic Campylobacter spp. by real-time PCR Microb Drug Resist 11 2005 40 47
11. S. Vacher, A. Menard, E. Bernard, and F. Megraud PCR-restriction fragment length polymorphism analysis for detection of point mutations associated with macrolide resistance in Campylobacter spp Antimicrob Agents Chemother 47 2003 1125 1128
12. S. Payot, L. Avrain, C. Magras, K. Praud, A. Cloeckaert, and E. Chaslus-Dancla Relative contribution of target gene mutation and efflux to fluoroquinolone and erythromycin resistance, in French poultry and pig isolates of Campylobacter coli Int J Antimicrob Agents 23 2004 468 472
13. H. Niwa, T. Chuma, K. Okamoto, and K. Itoh Rapid detection of mutations associated with resistance to erythromycin in Campylobacter jejuni/coli by PCR and line probe assay Int J Antimicrob Agents 18 2001 359 364
14. B. Vester, and S. Douthwaite Macrolide resistance conferred by base substitutions in 23S rRNA Antimicrob Agents Chemother 45 2001 1 12
15. M. Haanpera, P. Huovinen, and J. Jalava Detection and quantification of macrolide resistance mutations at positions 2058 and 2059 of the 23S rRNA gene by pyrosequencing Antimicrob Agents Chemother 49 2005 457 460
16. L. Mamelli, J.P. Amoros, J.M. Pagès, and J.M. Bolla A phenylalanine-arginine beta-naphthylamide sensitive multidrug efflux pump involved in intrinsic and acquired resistance of Campylobacter to macrolides Int J Antimicrob Agents 22 2003 237 241
17. S.Z. Doktor, V.D. Shortridge, J.M. Beyer, and R.K. Flamm Epidemiology of macrolide and/or lincosamide resistant Streptococcus pneumoniae clinical isolates with ribosomal mutations Diagn Microbiol Infect Dis 49 2004 47 52
18. H.S. Chittum, and W.S. Champney Ribosomal protein gene sequence changes in erythromycin-resistant mutants of Escherichia coli J Bacteriol 176 1994 6192 6198
19. M. Peric, B. Bozdogan, M.R. Jacobs, and P.C. Appelbaum Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates Antimicrob Agents Chemother 47 2003 1017 1022
20. Comité de l'Antibiogramme de la Société Francaise de Microbiologie. Concentrations, diamétres critiques et règles de lecture interpretative pour Campylobacter spp. Paris, France: Comité de l'Antibiogramme de la Société Francaise de Microbiologie; 2002. p. 44.
21. S.F. Altschul, T.L. Madden, and A.A. Schaffer Gapped BLAST and PSI-BLAST: a new generation of protein database search programs Nucleic Acids Res 25 1997 3389 3402
22. T. Schwede, J. Kopp, N. Guex, and M.C. Peitsch SWISS-MODEL: an automated protein homology-modeling server Nucleic Acids Res 31 2003 3381 3385
23. A. Tait-Kamradt, T. Davies, and P.C. Appelbaum Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America Antimicrob Agents Chemother 44 2000 3395 3401
24. B. Malbruny, K. Nagai, and M. Coquemont Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations J Antimicrob Chemother 49 2002 935 939
25. B. Malbruny, A. Canu, and B. Bozdogan Resistance to quinupristin- dalfopristin due to mutation of L22 ribosomal protein in Staphylococcus aureus Antimicrob Agents Chemother 46 2002 2200 2207
26. R.N. Jones, D.J. Farrell, and I. Morrissey Quinupristin-dalfopristin resistance in Streptococcus pneumoniae: novel L22 ribosomal protein mutation in two clinical isolates from the SENTRY antimicrobial surveillance program Antimicrob Agents Chemother 47 2003 2696 2698
27. J. Lin, L.O. Michel, and Q. Zhang CmeABC functions as a multidrug efflux system in Campylobacter jejuni Antimicrob Agents Chemother 46 2002 2124 2131
28. L. Pumbwe, and L.J. Piddock Identification and molecular characterization of CmeB, a Campylobacter jejuni multidrug efflux pump FEMS Microbiol Lett 206 2002 185 189